Shu-na Chen

Shenzhen Key Laboratory For Systems Medicine In Inflammatory Diseases
Shenzhen, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Integrative analysis of bulk and single-cell gene expression profiles to identify bone marrow mesenchymal cell heterogeneity and prognostic significance in multiple myeloma.

Integrative analysis of bulk and single-cell gene expression profiles to identify bone marrow mesenchymal cell heterogeneity and prognostic significance in multiple myeloma.

Journal: Journal of translational medicine
Published: April 02, 2025

Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome-scale CRISPR-Cas9 screening in myeloma cells.

Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome-scale CRISPR-Cas9 screening in myeloma cells.

Journal: British journal of haematology
Published: September 01, 2023

E2F2 modulates cell adhesion through the transcriptional regulation of PECAM1 in multiple myeloma.

E2F2 modulates cell adhesion through the transcriptional regulation of PECAM1 in multiple myeloma.

Journal: British journal of haematology
Published: December 08, 2022

TJP1 promotes vascular mimicry in bladder cancer by facilitating VEGFA expression and transcriptional activity through TWIST1.

TJP1 promotes vascular mimicry in bladder cancer by facilitating VEGFA expression and transcriptional activity through TWIST1.

Journal: Translational oncology
Published: November 27, 2022

Tight Junction Protein 1 Suppresses Kidney Renal Clear Cell Carcinoma Cells Proliferation by Inducing Autophagy.

Tight Junction Protein 1 Suppresses Kidney Renal Clear Cell Carcinoma Cells Proliferation by Inducing Autophagy.

Journal: International journal of medical sciences
Published: November 20, 2022

Engineered Cell Membrane Vesicles Expressing CD40 Alleviate System Lupus Nephritis by Intervening B Cell Activation.

Engineered Cell Membrane Vesicles Expressing CD40 Alleviate System Lupus Nephritis by Intervening B Cell Activation.

Journal: Small methods
Published: August 06, 2022

Case report: ISL2 is involved in malignant transformation in a patient with multiple relapsed oligodendroglioma.

Case report: ISL2 is involved in malignant transformation in a patient with multiple relapsed oligodendroglioma.

Journal: Frontiers in oncology
Published: June 14, 2022

Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer.

Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer.

Journal: Journal of cellular and molecular medicine
Published: April 19, 2021

Tight junction protein 1 promotes vasculature remodeling via regulating USP2/TWIST1 in bladder cancer.

Tight junction protein 1 promotes vasculature remodeling via regulating USP2/TWIST1 in bladder cancer.

Journal: Oncogene
Published: December 03, 2020

Methylation of the Promoter Region of the Tight Junction Protein-1 by DNMT1 Induces EMT-like Features in Multiple Myeloma.

Methylation of the Promoter Region of the Tight Junction Protein-1 by DNMT1 Induces EMT-like Features in Multiple Myeloma.

Journal: Molecular therapy oncolytics
Published: July 23, 2020

ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma.

ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma.

Journal: Oncogene
Published: June 03, 2020
Showing 1-11 of 11

Last Updated: 09/26/2026